Skip to content

Therapeutic Intervention in participants having deep carious lesion by Indirect Pulp Capping Treatment with three different biomaterials and evaluate the clinical and radiographic outcomes.

Odontogenic Responses of human dental pulp to indirect pulp treatment by different biomaterials - A Prospective Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067644
Enrollment
30
Registered
2024-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K025- Dental caries on pit and fissure surface

Interventions

Intervention1: Indirect Pulp Capping Treatment: Evaluate efficacy of eggshell derived hydroxyapatite, Light cure Resin Based material (Theracal LC) and MTA based material (Biodentine) clinically by ch

Sponsors

Narsinhbhai Patel Dental College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Tooth should be mature permanaent tooth showing closed apex in peroapical radiograph 2)Permanent posterior teeth with deep dentinal caries 3)Class I caries 4)teeth diagnosed with reversible pulpitis 5)Radiographically depth of caries should be more than 70 percentage or more than two thirds of dentin thickness

Exclusion criteria

Exclusion criteria: 1)Deciduous teeth 2)Allergy to egg protein 3)No pulpal exposure post completion of caries removal 4)Teeth showing signs if irreversible pulpitis 5)Extensive pulpal carious lesion 6)Acute pulpal inflammation 7)Pulp Necrosis 8)Pathological Mobility 9)Tooth showing internal external resorption 10)Periapical Abscess 11)Fistula 12)Patient on antibiotic or analgesic course within a week prior to the start of treatment

Design outcomes

Primary

MeasureTime frame
Determine which pulp capping agent has higher efficacy in pulp capping treatmentTimepoint: 1, 3,6 and 9 months

Secondary

MeasureTime frame
To compare and evaluate efficacy of EggShell derived Hydroxyapatite, Biodentine and Theracal LC as IPC agent clinically by checking postoperative pain, tenderness, neural sensibility, and radiographically by checking PDL space widening, presence of calcific barrier and periapical radiolucencyTimepoint: 1, 3,6 and 9 months

Countries

India

Contacts

Public ContactDr Krunali Jayswal

Narsinhbhai Patel Dental College and Hospital

atturkailash@gmail.com9727752499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026